About the Authors

Dilbinder K. Gill

Contributed equally to this work with: Dilbinder K. Gill, Yunda Huang

d.gill@imperial.ac.uk

Affiliation International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom

Yunda Huang

Contributed equally to this work with: Dilbinder K. Gill, Yunda Huang

Affiliation Statistical Center for HIV/AIDS Research and Prevention, Seattle, Washington, United States of America

Gail L. Levine

Affiliation Foundation for the National Institutes of Health, Bethesda, Maryland, United States of America

Anna Sambor

Affiliation Foundation for the National Institutes of Health, Bethesda, Maryland, United States of America

Donald K. Carter

Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Alicia Sato

Affiliation Statistical Center for HIV/AIDS Research and Prevention, Seattle, Washington, United States of America

Jakub Kopycinski

Affiliation International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom

Peter Hayes

Affiliation International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom

Bridget Hahn

Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Josephine Birungi

Affiliation Uganda Virus Research Institute, Entebbe, Uganda

Tony Tarragona-Fiol

Affiliation International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom

Hong Wan

Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

Mark Randles

Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

Andrew Raxworthy Cooper

Affiliation International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom

Aloysius Ssemaganda

Affiliation Uganda Virus Research Institute, Entebbe, Uganda

Lorna Clark

Affiliation International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom

Pontiano Kaleebu

Affiliation Uganda Virus Research Institute, Entebbe, Uganda

Steven G. Self

Affiliation Statistical Center for HIV/AIDS Research and Prevention, Seattle, Washington, United States of America

Richard Koup

Affiliation Vaccine Research Center, Bethesda, Maryland, United States of America

Blake Wood

Affiliation Statistical Center for HIV/AIDS Research and Prevention, Seattle, Washington, United States of America

M. Juliana McElrath

Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Josephine H. Cox

Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

John Hural

Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Jill Gilmour

Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: DKG YH RAK JG. Performed the experiments: ARC AS. Analyzed the data: DKG YH AS MJM JH. Contributed reagents/materials/analysis tools: DKG PJH JC JG. Wrote the paper: DKG YH GL JTK JC. Scientific Program Manager FNIH CTC-VIMC: GL. Program Manager FNIH: AS. HVTN Laboratory Manager: DC. Principle Scientist IAVI HIL: PJH. HVTN QC Manager: BH. UVRI laboratory Manager: JB. IAVI HIL Program manager: TT-F. Program Manager IAVI: HW. IAVI HIL QA Manager: MR. PI of UVRI Laboratory: PK. PI SCHARP: SS. PI CTC-VIMC: RAK. SCHARP Program manager: BW. PI HVTN: MJM. PI IAVI HIL: JG.